Landos Biopharma Price on June 20, 2023
LABPDelisted Stock | USD 4.02 0.15 3.60% |
If you're considering investing in Landos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Landos Biopharma stands at 4.02, as last reported on the 22nd of November, with the highest price reaching 4.28 and the lowest price hitting 3.94 during the day. We have found twenty-nine technical indicators for Landos Biopharma, which you can use to evaluate the volatility of the firm. Please verify Landos Biopharma's Downside Deviation of 4.51, risk adjusted performance of 0.0989, and Mean Deviation of 3.55 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Landos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Landos |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
LABP |
Based on monthly moving average Landos Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Landos Biopharma by adding Landos Biopharma to a well-diversified portfolio.
Related Headline
Angion Biomedica Headline on 1st of June 2023
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split by finance.yahoo.com
NEWTON, Mass., June 01, 2023 Angion Biomedia Corp. , a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, today announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. Angions common stock will begin trading on a split-adjusted basis when the market opens on June 2, 2023 under the new tradi
Landos Biopharma Valuation on June 20, 2023
It is possible to determine the worth of Landos Biopharma on a given historical date. On June 20, 2023 Landos was worth 3.87 at the beginning of the trading date compared to the closed value of 3.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Landos Biopharma stock. Still, in general, we apply an absolute valuation method to find Landos Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Landos Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Landos Biopharma's related companies.
Open | High | Low | Close | Volume | |
3.79 | 3.94 | 3.78 | 3.94 | 9,143 | |
06/20/2023 | 3.87 | 3.96 | 3.68 | 3.83 | 18,948 |
3.92 | 3.92 | 3.55 | 3.56 | 8,429 |
Backtest Landos Biopharma | | | Landos Biopharma History | | | Landos Biopharma Valuation | Previous | Next |
Landos Biopharma Trading Date Momentum on June 20, 2023
On June 21 2023 Landos Biopharma was traded for 3.56 at the closing time. The top price for the day was 3.92 and the lowest listed price was 3.55 . The trading volume for the day was 8.4 K. The trading history from June 21, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 7.05% . The trading delta at closing time against the current closing price is 1.31% . |
Landos Biopharma Fundamentals Correlations and Trends
By evaluating Landos Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Landos Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Landos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Landos Biopharma Stock history
Landos Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Landos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Landos Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Landos Biopharma stock prices may prove useful in developing a viable investing in Landos Biopharma
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia. Landos Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people.
Landos Biopharma Stock Technical Analysis
Landos Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Landos Biopharma Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Landos Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Landos Biopharma November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Landos Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Landos Biopharma shares will generate the highest return on investment. By undertsting and applying Landos Biopharma stock market strength indicators, traders can identify Landos Biopharma entry and exit signals to maximize returns
Landos Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Landos Biopharma's price direction in advance. Along with the technical and fundamental analysis of Landos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Landos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0989 | |||
Jensen Alpha | 0.5551 | |||
Total Risk Alpha | (0.06) | |||
Sortino Ratio | 0.0974 | |||
Treynor Ratio | (3.18) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |